For the Inventor, By the Inventor

Enter assignee name

Palo Alto, CA, United States of America

Anacor Pharmaceuticals, Inc.

USPTO Granted Patents = 70

CIPO Patents = 3

EPO Patents = 20

Trademarks = 6

Forward Citations = 963

Loading Chart...

Loading Chart...

96 inventors (with patents filed for the assignee):

Jacob J Plattner (54 out of 105 patents)

Tsutomu Akama (48 out of 59 patents)

Yong-Kang Zhang (37 out of 60 patents)

4. Vincent S Hernandez (30 out of 32 patents)

5. Stephen J Baker (27 out of 27 patents)

6. Kirk R Maples (25 out of 37 patents)

7. Michael Richard Kevin Alley (18 out of 18 patents)

8. Virginia J Sanders (18 out of 29 patents)

9. Carolyn Bellinger-Kawahara (13 out of 13 patents)

10. Karin M Hold (12 out of 12 patents)

11. Yvonne Freund (11 out of 11 patents)

12. Daitao Chen (11 out of 11 patents)

13. Robert Toms Jacobs (11 out of 24 patents)

14. Rajeshwar Singh (11 out of 38 patents)

15. Fernando Rock (10 out of 10 patents)

Core Competencies:

Crisaborole

Oxaborole Compounds

Benzoxaborole

Boron-Containing Molecules

Antiprotozoal Agents

Antiparasitic Agents

Anti-Inflammatory Agents

Tricyclic Compounds

70 patents: Sort by Forward Citations

1. 11773113 - Crystal forms of crisaborole in free form and preparation method and use thereof (2023-10-03),

2. 11691992 - Oxaborole analogs and uses thereof (2023-07-04),

3. 11578087 - Oxaborole esters and uses thereof (2023-02-14),

4. 11447506 - Crystal forms of crisaborole in free form and preparation method and use thereof (2022-09-20),

5. 11214582 - 4-substituted benzoxaborole compounds and uses thereof (2022-01-04),

6. 11161858 - Boron-containing small molecules as antiprotozoal agents (2021-11-02),

7. 11008345 - Boron-containing small molecules (2021-05-18),

8. 10961261 - Oxaborole analogs and uses thereof (2021-03-30),

9. 10882872 - Oxaborole esters and uses thereof (2021-01-05),

10. 10858376 - Tricyclic benzoxaborole compounds and uses thereof (2020-12-08),

11. 10774096 - 4-substituted benzoxaborole compounds and uses thereof (2020-09-15),

12. 10669291 - Boron-containing small molecules as antiprotozoal agents (2020-06-02),

13. 10562921 - Oxaborole esters and uses thereof (2020-02-18),

14. 10533021 - Boron-containing small molecules (2020-01-14),

15. 10526352 - Tricyclic benzoxaborole compounds and uses thereof (2020-01-07),

Anacor Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing novel small-molecule therapeutics for the treatment of various skin diseases. With a unique expertise in boron chemistry, their approach has led to the development of innovative products like Kerydin® (tavaborole), an antifungal medication for toenail fungus. Anacor is dedicated to improving patient care by addressing significant unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

70 Patents

#36 in Palo Alto, CA

#1,194 in California

#5,013 in US

#10,208 in the World

Palo Alto, CA, United States of America

Anacor Pharmaceuticals, Inc.

Forward Citations = 963

96 inventors:

Jacob J Plattner (54 out of 105 patents)

Tsutomu Akama (48 out of 59 patents)

Yong-Kang Zhang (37 out of 60 patents)

4. Vincent S Hernandez (30 out of 32 patents)

5. Stephen J Baker (27 out of 27 patents)

Please report any incorrect information to support@idiyas.com

Loading…